Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SkinHealth Systems Inc.SKIN · Entity 6863 | Chief Revenue Oficer | February 04, 2023 | June 11, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SkinHealth Systems Inc.
Report date February 04, 2023 · Filed June 11, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 806,313 |
Reported balance
After 2023-02-04 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-02-04 · Tax withholding · Disposed 8,972 · Balance 806,313 F1: Represents shares withheld by the issuer to satisfy tax withholding requirements on vesting of restricted stock units and does not represent a sale. F2: Shares reported in Column 5 include the acquisition of 2,500 shares, and 4,165 shares, respectively, of Class A Common Stock acquired by the reporting person under two separate purchase periods under the Company's 2021 Employee Stock Purchase Plan. |
| Class A Common StockSEC Table I · non-derivative | Direct | 795,680 |
Reported balance
After 2024-02-04 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2024-02-04 · Tax withholding · Disposed 10,633 · Balance 795,680 F1: Represents shares withheld by the issuer to satisfy tax withholding requirements on vesting of restricted stock units and does not represent a sale. |
| Class A Common StockSEC Table I · non-derivative | Direct | 789,324 |
Reported balance
After 2024-03-01 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2024-03-01 · Tax withholding · Disposed 6,356 · Balance 789,324 F1: Represents shares withheld by the issuer to satisfy tax withholding requirements on vesting of restricted stock units and does not represent a sale. |
| Class A Common StockSEC Table I · non-derivative | Direct | 778,112 |
Reported balance
After 2024-04-05 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2024-04-05 · Tax withholding · Disposed 11,212 · Balance 778,112 F1: Represents shares withheld by the issuer to satisfy tax withholding requirements on vesting of restricted stock units and does not represent a sale. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld by the issuer to satisfy tax withholding requirements on vesting of restricted stock units and does not represent a sale.
F2: Shares reported in Column 5 include the acquisition of 2,500 shares, and 4,165 shares, respectively, of Class A Common Stock acquired by the reporting person under two separate purchase periods under the Company's 2021 Employee Stock Purchase Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 09, 2024 Filed Apr 11, 2024 20:40 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | GrantClass A Common Stock | 243,506 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-015847 · wk-form4_1712868012.xml · nonDerivative · entry 1 Watson Daniel Copell · CIK 0001860764 · Chief Revenue Oficer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 808,620 F1 · kind: Represents a grant of restricted stock units that vest in one-third increments on each of the first three anniversaries of the grant date of April 9, 2024, in each case subject to continued service through the vesting date and certain acceleration rights. F1 · price: Represents a grant of restricted stock units that vest in one-third increments on each of the first three anniversaries of the grant date of April 9, 2024, in each case subject to continued service through the vesting date and certain acceleration rights. Read SEC document |
| April 05, 2024 Filed Jun 11, 2024 23:09 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | Tax withholdingClass A Common Stock | 11,212 | $3.71 | $41,596.52 |
DisclosureSEC source: 0001628280-24-027739 · wk-form4_1718147383.xml · nonDerivative · entry 4 Watson Daniel Copell · CIK 0001860764 · Chief Revenue Oficer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 778,112 F1 · kind: Represents shares withheld by the issuer to satisfy tax withholding requirements on vesting of restricted stock units and does not represent a sale. Read SEC document |
| March 01, 2024 Filed Jun 11, 2024 23:09 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | Tax withholdingClass A Common Stock | 6,356 | $3.73 | $23,707.88 |
DisclosureSEC source: 0001628280-24-027739 · wk-form4_1718147383.xml · nonDerivative · entry 3 Watson Daniel Copell · CIK 0001860764 · Chief Revenue Oficer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 789,324 F1 · kind: Represents shares withheld by the issuer to satisfy tax withholding requirements on vesting of restricted stock units and does not represent a sale. Read SEC document |
| February 04, 2024 Filed Jun 11, 2024 23:09 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | Tax withholdingClass A Common Stock | 10,633 | $2.98 | $31,686.34 |
DisclosureSEC source: 0001628280-24-027739 · wk-form4_1718147383.xml · nonDerivative · entry 2 Watson Daniel Copell · CIK 0001860764 · Chief Revenue Oficer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 795,680 F1 · kind: Represents shares withheld by the issuer to satisfy tax withholding requirements on vesting of restricted stock units and does not represent a sale. Read SEC document |
| November 29, 2023 Filed Dec 1, 2023 21:17 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | GrantClass A Common Stock | 156,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-040452 · wk-form4_1701465421.xml · nonDerivative · entry 1 Watson Daniel Copell · CIK 0001860764 · Chief Revenue Oficer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 565,114 F1 · kind: Represents a retention award of restricted stock units (the "RSUs"). Fifty percent (50%) of the RSUs will vest on December 1, 2024, and the remaining fifty percent (50%) of the RSUs will vest on June 1, 2025, in each case subject to continued service through the applicable vesting date and certain acceleration rights. F1 · price: Represents a retention award of restricted stock units (the "RSUs"). Fifty percent (50%) of the RSUs will vest on December 1, 2024, and the remaining fifty percent (50%) of the RSUs will vest on June 1, 2025, in each case subject to continued service through the applicable vesting date and certain acceleration rights. Read SEC document |
| April 05, 2023 Filed Apr 6, 2023 23:03 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | GrantClass A Common Stock | 94,265 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-011059 · wf-form4_168082216923375.xml · nonDerivative · entry 1 Watson Daniel Copell · CIK 0001860764 · Chief Revenue Oficer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 408,864 F1 · kind: Represents a grant of restricted stock units that vest in one-third increments on each of the first three anniversaries of the grant date of April 5, 2023, in each case subject to continued service through the vesting date and certain acceleration rights. F1 · price: Represents a grant of restricted stock units that vest in one-third increments on each of the first three anniversaries of the grant date of April 5, 2023, in each case subject to continued service through the vesting date and certain acceleration rights. Read SEC document |
| March 01, 2023 Filed Mar 7, 2023 01:43 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | GrantClass A Common Stock | 17,560 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001818093-23-000010 · wf-form4_167815340148435.xml · nonDerivative · entry 1 Watson Daniel Copell · CIK 0001860764 · Chief Revenue Oficer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,599 F1 · kind: Represents a grant of restricted stock units that vests in one year on the anniversary of the grant date of March 1, 2023, subject to continued service through the vesting date and certain acceleration rights. F1 · price: Represents a grant of restricted stock units that vests in one year on the anniversary of the grant date of March 1, 2023, subject to continued service through the vesting date and certain acceleration rights. F2 · balance_after: These shares include 1,843 shares of Class A Common Stock acquired by the reporting person under the Company's 2021 Employee Stock Purchase Plan Read SEC document |
| February 04, 2023 Filed Jun 11, 2024 23:09 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | Tax withholdingClass A Common Stock | 8,972 | $12.90 | $115,738.80 |
DisclosureSEC source: 0001628280-24-027739 · wk-form4_1718147383.xml · nonDerivative · entry 1 Watson Daniel Copell · CIK 0001860764 · Chief Revenue Oficer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 806,313 F1 · kind: Represents shares withheld by the issuer to satisfy tax withholding requirements on vesting of restricted stock units and does not represent a sale. F2 · balance_after: Shares reported in Column 5 include the acquisition of 2,500 shares, and 4,165 shares, respectively, of Class A Common Stock acquired by the reporting person under two separate purchase periods under the Company's 2021 Employee Stock Purchase Plan. Read SEC document |
| April 28, 2022 Filed May 2, 2022 21:27 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | GrantPerformance Restricted Stock Units · Derivative | 187,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001818093-22-000057 · wf-form4_165152680527840.xml · derivative · entry 1 Watson Daniel Copell · CIK 0001860764 · Executive VP Americas Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,500 Underlying: Class A Common Stock · 187,500 shares Expires not disclosed F1 · derivative.exercise_price: Represents an award of performance-based restricted stock units that may be earned and vest (from 0-100%) over a four-year performance period based on the achievement of performance goals related to the Company's stock price and continued employment with the Company through the end of the performance period. Each performance restricted stock unit converts on a one-for-one basis to Class A Common Stock upon vesting. F1 · price: Represents an award of performance-based restricted stock units that may be earned and vest (from 0-100%) over a four-year performance period based on the achievement of performance goals related to the Company's stock price and continued employment with the Company through the end of the performance period. Each performance restricted stock unit converts on a one-for-one basis to Class A Common Stock upon vesting. F1 · derivative.exercise_date: Represents an award of performance-based restricted stock units that may be earned and vest (from 0-100%) over a four-year performance period based on the achievement of performance goals related to the Company's stock price and continued employment with the Company through the end of the performance period. Each performance restricted stock unit converts on a one-for-one basis to Class A Common Stock upon vesting. F1 · derivative.expiration_date: Represents an award of performance-based restricted stock units that may be earned and vest (from 0-100%) over a four-year performance period based on the achievement of performance goals related to the Company's stock price and continued employment with the Company through the end of the performance period. Each performance restricted stock unit converts on a one-for-one basis to Class A Common Stock upon vesting. Read SEC document |
| February 04, 2022 Filed Feb 9, 2022 01:07 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | GrantClass A Common Stock | 77,835 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001818093-22-000023 · wf-form4_164436883553171.xml · nonDerivative · entry 1 Watson Daniel Copell · CIK 0001860764 · Executive VP Americas Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,196 F1 · kind: Represents a grant of restricted stock units that vest in one-third increments on each of the first three anniversaries of the grant date of February 4, 2022, in each case subject to continued service through the vesting date and certain acceleration rights. F1 · price: Represents a grant of restricted stock units that vest in one-third increments on each of the first three anniversaries of the grant date of February 4, 2022, in each case subject to continued service through the vesting date and certain acceleration rights. Read SEC document |
| August 25, 2021 Filed Aug 26, 2021 21:27 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | OtherClass A Common Stock | 363 | $0.00 | $0.00 |
DisclosureSEC source: 0001818093-21-000041 · wf-form4_163001320162911.xml · nonDerivative · entry 1 Watson Daniel Copell · CIK 0001860764 · Executive VP Americas Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,361 F1 · kind: The reported acquisition reflects working capital adjustment shares issued pursuant that certain Agreement and Plan of Merger, dated as of December 8, 2020, by and among Vesper Health Acquisition Corp, Hydrate Merger Sub I, Hydrate Merger Sub II LLC, LCP Edge Intermediate, Inc. the indirect parent of Edge Systms LLC d/b/a the HydraFacial Company and LCP Edge Holdco, LLC. F1 · price: The reported acquisition reflects working capital adjustment shares issued pursuant that certain Agreement and Plan of Merger, dated as of December 8, 2020, by and among Vesper Health Acquisition Corp, Hydrate Merger Sub I, Hydrate Merger Sub II LLC, LCP Edge Intermediate, Inc. the indirect parent of Edge Systms LLC d/b/a the HydraFacial Company and LCP Edge Holdco, LLC. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 23:14 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | OtherClass A Common Stock | 38,429 | $0.00 | $0.00 |
DisclosureSEC source: 0001818093-21-000027 · wf-form4_162673643649192.xml · nonDerivative · entry 1 Watson Daniel Copell · CIK 0001860764 · Executive VP Americas Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,998 F1 · kind: The reported acquisition reflects earnout shares issued pursuant that certain Agreement and Plan of Merger, dated as of December 8, 2020, by and among Vesper Health Acquisition Corp, Hydrate Merger Sub I, Hydrate Merger Sub II LLC, LCP Edge Intermediate, Inc. the indirect parent of Edge Systems LLC d/b/a the HydraFacial Company and LCP Edge Holdco, LLC. F1 · price: The reported acquisition reflects earnout shares issued pursuant that certain Agreement and Plan of Merger, dated as of December 8, 2020, by and among Vesper Health Acquisition Corp, Hydrate Merger Sub I, Hydrate Merger Sub II LLC, LCP Edge Intermediate, Inc. the indirect parent of Edge Systems LLC d/b/a the HydraFacial Company and LCP Edge Holdco, LLC. Read SEC document |
| May 20, 2021 Filed May 21, 2021 23:59 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | OtherClass A Common Stock | 178,569 | $0.00 | $0.00 |
DisclosureSEC source: 0001818093-21-000012 · wf-form4_162164152205948.xml · nonDerivative · entry 1 Watson Daniel Copell · CIK 0001860764 · Executive VP Americas Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,569 F1 · kind: The reported acquisition is the result of distributions for no consideration made by LCP Edge Holdco LLC to certain of its unitholders, including the reporting person, in redemption of their respective interests in LCP Edge Holdco LLC. Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:22 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | GrantStock Options (right to buy) · Derivative | 310,000 | $0.00 Strike: $12.85 | $0.00 |
DisclosureSEC source: 0000899243-21-019001 · doc4.xml · derivative · entry 1 Watson Daniel Copell · CIK 0001860764 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,000 Underlying: Common Stock · 310,000 shares Expires 2031-05-06 F1 · security: Represents a grant of stock options under The Beauty Health Company 2021 Incentive Award Plan. Subject to accelerated vesting in certain circumstances, twenty-five percent (25%) of the stock options are scheduled to vest on each of the first four anniversaries of May 6, 2021, as long as the reporting person remains in the service of The Beauty Health Company through the applicable vesting date. F1 · derivative.exercise_date: Represents a grant of stock options under The Beauty Health Company 2021 Incentive Award Plan. Subject to accelerated vesting in certain circumstances, twenty-five percent (25%) of the stock options are scheduled to vest on each of the first four anniversaries of May 6, 2021, as long as the reporting person remains in the service of The Beauty Health Company through the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.